Parkman Healthcare Partners’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-216,868
| Closed | -$4.11M | – | 106 |
|
|
2023
Q2 | $4.11M | Buy |
216,868
+30,823
| +17% | +$585K | 0.71% | 43 |
|
|
2023
Q1 | $2.89M | Buy |
186,045
+28,039
| +18% | +$435K | 0.63% | 49 |
|
|
2022
Q4 | $2.8M | Buy |
+158,006
| New | +$2.8M | 0.75% | 48 |
|
|
2021
Q1 | – | Sell |
-60,781
| Closed | -$2.81M | – | 90 |
|
|
2020
Q4 | $2.81M | Sell |
60,781
-89,370
| -60% | -$4.13M | 0.72% | 52 |
|
|
2020
Q3 | $5.28M | Buy |
150,151
+25,026
| +20% | +$881K | 1.4% | 30 |
|
|
2020
Q2 | $3.05M | Buy |
125,125
+85,000
| +212% | +$2.07M | 0.86% | 41 |
|
|
2020
Q1 | $625K | Buy |
+40,125
| New | +$625K | 0.29% | 62 |
|